2023-11-15T22:55:41-06:00 2022-12-31 061671819 PKF O'CONNOR DAVIES ADVISORY LLC 245 PARK AVENUE 12TH FLOOR NEW YORK NY 10167 990 2022-01-01 133299366 AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE INC AMER 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO PRESIDENT/CEO 2125665555 2023-11-15 1 MARK PARRINO 999009999 1 EVA MRUK P00543254 2122862600 2023-11-14 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z AATOD MARK W PARRINO 225 VARICK STREET 4TH FL NEW YORK NY 10014 1900007 0 X WWW.AATOD.ORG X 1985 NY TO ENHANCE THE QUALITY OF PATIENT CARE IN COMPREHENSIVE OPIOID TREATMENT PROGRAMS. 31 30 4 35 0 0 199697 333606 1227805 1565618 91 43 13055 740 1440648 1900007 0 0 0 0 534088 554623 0 0 63741 657717 1299886 1191805 1854509 248843 45498 950559 1280746 193799 478488 756760 802258 X TO ENHANCE THE QUALITY OF PATIENT CARE IN TREATMENT PROGRAMS BY PROMOTING THE GROWTH AND DEVELOPMENT OF COMPREHENSIVE OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES. 0 0 830432 0 1048795 NATIONAL CONFERENCE- AATOD PRODUCES NATIONAL CONFERENCES ON AN EIGHTEEN MONTH CYCLE. THESE CONFERENCES PROVIDE AN OPPORTUNITY TO INTERESTED PARTIES TO LEARN ABOUT THE MOST CURRENT EVIDENCE BASED PRACTICES IN OUR FIELD. 363463 0 363463 RX OPIOID STUDY- TO BETTER UNDERSTAND THE IMPACT OF PRESCRIPTION OPIOID USE ON ADMISSIONS TO OPIOID TREATMENT PROGRAMS. SEVENTY FIVE TREATMENT PROGRAMS PROVIDE TREND ANALYSIS DATA. 79258 0 OPIOID TREATMENT PROGRAMS STUDY- TO INCREASE ACCESS TO THE TREATMENT OF OPIOID ADDICTION THROUGH OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES OF AMERICA. 146952 0 153360 MEMBERSHIP - A PORTION OF THE MEMBERSHIP DUES RELATES TO RETURN BENEFITS TO THE MEMBERS. BENEFITS INCLUDE EVENT PRIORITY, UP-TO-DATE RESEARCH FINDINGS, AND MORE. 146952 0 153360 1420105 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 4 1 0 0 0 0 0 0 0 0 0 0 0 0 X 31 30 0 0 0 0 1 0 0 1 1 0 0 1 1 0 0 0 0 1 0 0 NY X X MARK PARRINO 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO MPA PRESIDENT/CEO 40.00 X X 214356 0 26582 JANICE F KAUFFMAN FIRST V.P. 1.00 X X 0 0 0 ANN JAMIESON SECOND V.P. 1.00 X X 0 0 0 ERIN LACOURT SECRETARY 1.00 X X 0 0 0 TINA BECKLEY SECRETARY (THRU JUNE 2022) 1.00 X X 0 0 0 MICHAEL RIZZI TREASURER 1.00 X X 0 0 0 RICHARD BILANGI DIRECTOR 1.00 X 0 0 0 DAVID BLAKENSHIP DIRECTOR 1.00 X 0 0 0 ANGELA BONAGUIDI DIRECTOR 1.00 X 0 0 0 HOLLY BROCE DIRECTOR 1.00 X 0 0 0 SUSAN CASE DIRECTOR 1.00 X 0 0 0 DAVID CASSISE DIRECTOR 1.00 X 0 0 0 MISTY CALLINOR DIRECTOR 1.00 X 0 0 0 BRIAN CRISSMAN DIRECTOR 1.00 X 0 0 0 BRIAN FOSS DIRECTOR (THRU MAR 2022) 1.00 X 0 0 0 CHERYL L GARDINE DIRECTOR (THRU FEB 2022) 1.00 X 0 0 0 KENNY HOUSE DIRECTOR 1.00 X 0 0 0 LINDA HURLEY DIRECTOR 1.00 X 0 0 0 JASON KLETTER DIRECTOR 1.00 X 0 0 0 G DAVY KNEESSY DIRECTOR 1.00 X 0 0 0 ROBERT LAMBERT DIRECTOR 1.00 X 0 0 0 CHRISTINE MARTIN DIRECTOR 1.00 X 0 0 0 A DUSTIN METS DIRECTOR 1.00 X 0 0 0 PETER F MORRIS DIRECTOR 1.00 X 0 0 0 JOHN MULLEN DIRECTOR 1.00 X 0 0 0 JOSH NIRELLA DIRECTOR 1.00 X 0 0 0 OMAR CORRO DIRECTOR 1.00 X 0 0 0 STACEY PEARCE DIRECTOR 1.00 X 0 0 0 EVELYN REINHARDT DIRECTOR (THRU JUNE 2022) 1.00 X 0 0 0 MARGARET B RIZZO DIRECTOR 1.00 X 0 0 0 SHAREL DOWNS DIRECTOR 1.00 X 0 0 0 ALLEGRA SCHORR DIRECTOR 1.00 X 0 0 0 DINITA SMITH DIRECTOR 1.00 X 0 0 0 STEVEN SMITH DIRECTOR (THRU JUNE 2022) 1.00 X 0 0 0 NICK STAVROS DIRECTOR 1.00 X 0 0 0 KENNETH STOLLER MD DIRECTOR 1.00 X 0 0 0 214356 0 26582 1 0 1 0 0 333606 333606 NATIONAL CONFERENCE 900099 1048795 1048795 RX OPIOID STUDY 900099 363463 363463 MEMBERSHIP DUES 900099 153360 153360 1565618 43 43 REFUNDS & CC POINTS 900099 740 740 740 1900007 1565618 0 783 270947 139968 98869 32110 188677 117449 64420 6808 11428 5803 4722 903 49853 25314 20599 3940 33718 17121 13932 2665 98142 98142 126416 74828 41598 9990 3635 2152 1196 287 2862 2862 75415 53956 19045 2414 17225 10196 5668 1361 120703 37361 83342 6593 3902 2170 521 759326 748293 8896 2137 2441 1445 803 193 626 626 5217 3088 1717 412 PROGRAM INCENTIVES 78225 78225 BAD DEBT EXPENSE 3060 3060 1854509 1420105 370663 63741 503629 126961 217231 217273 149283 329338 72080 280074 5310 5599 29626 25701 3026 3925 0 317576 950559 1280746 80100 65999 2880 0 25174 25259 85645 387230 193799 478488 X 623090 615760 133670 186498 756760 802258 950559 1280746 45498 0 X X 0 1 X 1 0 X 324967 311388 218496 119697 333606 1308154 1723378 1667533 595851 1227805 1565618 6780185 2048345 1978921 814347 1347502 1899224 8088339 0 322173 292093 316551 324233 344463 1599513 322173 292093 316551 324233 344463 1599513 6488826 21 31 70 91 43 256 21 31 70 91 43 256 6598 8620 2277 13055 740 31290 2054964 1987572 816694 1360648 1900007 8119885 0.79910 0.74020 0.00000 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2018 AMOUNT: $ 6,598. 2019 AMOUNT: $ 8,620. 2020 AMOUNT: $ 2,277. 2021 AMOUNT: $ 13,055. 2022 AMOUNT: $ 740. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8380 4455 3925 21246 21246 0 3925 RIGHT-OF-USE ASSET 317576 317576 LEASE LIABILITY 387230 387230 X 1900007 0 1900007 0 1900007 1854509 0 1854509 0 1854509 PART X, LINE 2: THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE ORGANIZATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR YEARS PRIOR TO DECEMBER 31, 2019. X X X 0 0 0 0 0 0 0 1 0 MARK W PARRINO MPA PRESIDENT/CEO 201932 0 12000 0 424 0 10000 0 16582 0 240938 0 0 0 PART I, LINE 7 THE ORGANIZATION PAID THE PRESIDENT/CEO A BOARD-APPROVED, PERFORMANCE-BASED BONUS IN 2022. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION'S MEMBERSHIP IS OPEN TO INDIVIDUALS AND STATE OR COUNTRY ASSOCIATIONS INTERESTED IN FURTHERING MEDICATION ASSISTED TREATMENT: A. STATE AND COUNTRY ASSOCIATION MEMBERS (ASSOCIATIONS WITH A MINIMUM OF 3 PROVIDERS): EACH MEMBER IN THIS CLASS NOMINATES A BOD DIRECTOR TO REPRESENT THEM FOR 4 YEAR TERM. B. MEMBERS AT LARGE (INDIVIDUALS WITH EXPERTISE): EACH MEMBER IN THIS CLASS HAS VOTING RIGHTS AT GENERAL MEMBERSHIP MEETINGS FOR 4 YEAR TERM. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE PRESIDENT, THE TREASURER, AND FINANCE COMMITTEE BEFORE FILING. THE FINAL FORM 990 IS PROVIDED TO THE FULL BOARD OF DIRECTORS BEFORE E-FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE, ACTING AS THE COMPENSATION COMMITTEE, CONDUCTS ANNUAL REVIEWS OF THE PRESIDENT'S PERFORMANCE AND COMPENSATION. EVERY THIRD YEAR THE EXECUTIVE COMMITTEE REVIEWS COMPARABILITY DATA AND SETS NEW COMPENSATION LEVELS TO BE REFLECTED IN THE PRESIDENT'S THREE YEAR CONTRACT. THE CONTRACT AS PROPOSED BY THE EXECUTIVE COMMITTEE IS THEN SUBMITTED TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. THIS PROCESS LAST OCCURED IN 2022. ALL DECISIONS WERE DOCUMENTED IN THE MINUTES OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 UPON REQUEST, AATOD MAKES AVAILABLE TO THE PUBLIC ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS A FINANCE COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND SELECTION OF THE INDEPENDENT AUDITOR. THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.